Safety and efficacy of azacitidine in myelodysplastic syndromes
about
Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectivesLow-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II reportEnhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia.CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expressionAzacitidine in the management of patients with myelodysplastic syndromes.MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.Promises and challenges of anticancer drugs that target the epigenome.Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer.A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions.Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.
P2860
Q26999187-692A4286-A0EE-4E34-9522-0AC055B64911Q33744733-7E083303-AA0D-485E-AE57-DAE3AF56AAC8Q33910609-E015B7CF-2CE6-4ABE-B8D1-D098AC49697FQ34273735-39F8B37B-0ED1-4776-B2B8-9FA016CA9506Q34636402-50C61FFB-8F1F-46FA-99DB-6C689F55FC53Q36768610-EC6AB1B7-2370-4A20-BEBA-104B8964A863Q37937737-D70CE790-E183-482F-8E1B-82EC332E9A70Q37962596-B8193790-CBD0-4DF4-B99F-C32153166B84Q37996270-B5439190-E372-46CC-93EC-F0480125F8F3Q42177219-02C30C9B-9AEB-4E87-ADB8-0F9B2678040EQ42264992-5F33A37C-BF6B-4A8B-8EE8-873E1E72C09A
P2860
Safety and efficacy of azacitidine in myelodysplastic syndromes
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Safety and efficacy of azacitidine in myelodysplastic syndromes
@ast
Safety and efficacy of azacitidine in myelodysplastic syndromes
@en
Safety and efficacy of azacitidine in myelodysplastic syndromes
@nl
type
label
Safety and efficacy of azacitidine in myelodysplastic syndromes
@ast
Safety and efficacy of azacitidine in myelodysplastic syndromes
@en
Safety and efficacy of azacitidine in myelodysplastic syndromes
@nl
prefLabel
Safety and efficacy of azacitidine in myelodysplastic syndromes
@ast
Safety and efficacy of azacitidine in myelodysplastic syndromes
@en
Safety and efficacy of azacitidine in myelodysplastic syndromes
@nl
P2093
P2860
P921
P356
P1476
Safety and efficacy of azacitidine in myelodysplastic syndromes
@en
P2093
Carlos E Vigil
Guillermo Garcia-Manero
Taida Martin-Santos
P2860
P356
10.2147/DDDT.S3143
P407
P577
2010-01-01T00:00:00Z
2010-09-24T00:00:00Z